Search Results - "Reynhardt, Kai O."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Prediction of clinical pharmacokinetics of AMG 181, a human anti‐α4β7 monoclonal antibody for treating inflammatory bowel diseases

    Prediction of clinical pharmacokinetics of AMG 181, a human anti‐α4β7 monoclonal antibody for treating inflammatory bowel diseases by Li, Hong, Köck, Kathleen, Wisler, John A., Rees, William A., Prince, Peter J., Reynhardt, Kai O., Hsu, Hailing, Yu, Zhigang, Borie, Dominic C., Salinger, David H., Pan, Wei‐Jian

    Published in Pharmacology research & perspectives (01-02-2015)
    “…The purpose of this study was to predict a safe starting dose of AMG 181, a human anti‐α4β7 antibody for treating inflammatory bowel diseases, based on…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Sa1206 Multiple-Dose Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of AMG 181, a Human Anti-a4β7 Antibody for Treating Inflammatory Bowel Diseases (IBD)

    Sa1206 Multiple-Dose Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of AMG 181, a Human Anti-a4β7 Antibody for Treating Inflammatory Bowel Diseases (IBD) by Pan, Wei-Jian, Sullivan, Barbara A, Rees, William A, Evangelista, Christine M, Doherty, David R, Prince, Peter J, Reynhardt, Kai O, Zhou, Kefei, Yen, Mark, Hooper, Michele M, Lee, Jonathan, Yu, Zhigang, Hsu, Hailing, Borie, Dominique C

    Published in Gastroenterology (New York, N.Y. 1943) (01-05-2013)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Sa1207 Pharmacokinetics/Pharmacodynamics (PK/PD), Efficacy, and Safety of AMG 181 in Subjects With Active, Mild to Moderate Ulcerative Colitis - An Initial Assessment

    Sa1207 Pharmacokinetics/Pharmacodynamics (PK/PD), Efficacy, and Safety of AMG 181 in Subjects With Active, Mild to Moderate Ulcerative Colitis - An Initial Assessment by Pan, Wei-Jian, Radford-Smith, Graham, Andrews, Jane M, Schwartz, Howard I, Sullivan, Barbara A, Evangelista, Christine M, Rees, William A, Doherty, David R, Prince, Peter J, Reynhardt, Kai O, Zhou, Kefei, Johnson, Justo Sierra, Treacy, Anthony M, Lee, Jonathan, Yu, Zhigang, Borie, Dominique C

    Published in Gastroenterology (New York, N.Y. 1943) (01-05-2013)
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Su2082 Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Amg 181, a Fully Human Anti-α4β7 Antibody for Treating Inflammatory Bowel Diseases (IBD)

    Su2082 Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Amg 181, a Fully Human Anti-α4β7 Antibody for Treating Inflammatory Bowel Diseases (IBD) by Pan, Wei-Jian, Sullivan, Barbara A, Evangelista, Christine M, Doherty, David R, Tam, Chi-Yan J, Patel, Sonal K, Prince, Peter J, Reynhardt, Kai O, Rees, William A, Hsu, Hailing, Zhou, Kefei, Gu, Wen, Yen, Mark, Haller, Christine A, Dodson, Susanna, Yu, Zhigang, Wienkers, Larry C, Borie, Dominique C

    Published in Gastroenterology (New York, N.Y. 1943) (01-05-2012)
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Prediction of clinical pharmacokinetics of AMG 181, a human anti-α 4 β 7 monoclonal antibody for treating inflammatory bowel diseases

    Prediction of clinical pharmacokinetics of AMG 181, a human anti-α 4 β 7 monoclonal antibody for treating inflammatory bowel diseases by Li, Hong, Köck, Kathleen, Wisler, John A, Rees, William A, Prince, Peter J, Reynhardt, Kai O, Hsu, Hailing, Yu, Zhigang, Borie, Dominic C, Salinger, David H, Pan, Wei-Jian

    Published in Pharmacology research & perspectives (01-02-2015)
    “…The purpose of this study was to predict a safe starting dose of AMG 181, a human anti-α 4 β 7 antibody for treating inflammatory bowel diseases, based on…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: